BG102009A - Method for the treatment of manic and two-pole disease - Google Patents

Method for the treatment of manic and two-pole disease

Info

Publication number
BG102009A
BG102009A BG102009A BG10200997A BG102009A BG 102009 A BG102009 A BG 102009A BG 102009 A BG102009 A BG 102009A BG 10200997 A BG10200997 A BG 10200997A BG 102009 A BG102009 A BG 102009A
Authority
BG
Bulgaria
Prior art keywords
treatment
manic
disease
pole
relates
Prior art date
Application number
BG102009A
Other languages
Bulgarian (bg)
Other versions
BG63379B1 (en
Inventor
Atul PANDE
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1996/005898 external-priority patent/WO1996036328A1/en
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of BG102009A publication Critical patent/BG102009A/en
Publication of BG63379B1 publication Critical patent/BG63379B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a new therapeutical application ofgabapentine, to its derivatives and to pharmaceutical salts. Thecompounds are used for the treatment of manias in all their forms- acute or chronic, single or repeating, related to depression ornot. The invention also relates to the prophylaxy of the 2-poledisease.8 claims
BG102009A 1996-04-26 1997-10-31 Method for the treatment of manic and two-pole disease BG63379B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1996/005898 WO1996036328A1 (en) 1995-05-15 1996-04-26 A method of treatment of mania and bipolar disorder
US44057097A 1997-05-15 1997-05-15

Publications (2)

Publication Number Publication Date
BG102009A true BG102009A (en) 1998-11-30
BG63379B1 BG63379B1 (en) 2001-12-29

Family

ID=23749282

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102009A BG63379B1 (en) 1996-04-26 1997-10-31 Method for the treatment of manic and two-pole disease

Country Status (1)

Country Link
BG (1) BG63379B1 (en)

Also Published As

Publication number Publication date
BG63379B1 (en) 2001-12-29

Similar Documents

Publication Publication Date Title
ID28003A (en) ADAMANTANA'S DEMONS
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
BG101118A (en) Therapeutical compounds
EP0703785B8 (en) Methods for treating muscle diseases and disorders
MX9704030A (en) 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
ATE238038T1 (en) LIPOSOMAL FORMULATIONS OF MITOXANTRONE
DK1036058T3 (en) adamantane
EP0869804A4 (en) COMPLETE AND NON-COMPLETE TISSUE FILLERS, PROCESSES FOR THE PRODUCTION AND USE THEREOF
CA2258895A1 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
PT998287E (en) USES OF LEVOBUPIVACAINE
FI972308A0 (en) 2-Substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions containing them and methods for their use
TR199701121T1 (en) Benazepril or combination compositions containing benazepril and valsartan.
CA2016575A1 (en) Method of aiding cessation of smoking
BG105275A (en) Tan-1057 derivatives
TR200000455T2 (en) The use of fanquinone in the treatment of Alzheimer's disease.
BG102667A (en) Diosgenine-containing composition
EP0744176A3 (en) Methods for inhibiting bone loss
PL322284A1 (en) Derivatives of aminoteralin useful in treating diseases of cardiovascular system
CA2260863A1 (en) Treatment of psychotic disorders
WO1999051617A3 (en) FORM VI 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-(β-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE
BG102009A (en) Method for the treatment of manic and two-pole disease
IT8519907A0 (en) COSMETIC PHARMACEUTICAL PRODUCT, PARTICULARLY FOR THE TREATMENT OF ACNE AND SEBORHEA.
AU644500B2 (en) 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma
FI965171A7 (en) Use of enantiomers of oxazophosphorines, e.g. ifosfamide, in the treatment of tumors to reduce side effects